je.st
news
Bayer upbeat, plans chemicals IPO by 2016
2015-03-11 11:24:05| Chemicals - Topix.net
Germany's Bayer AG is forecasting strong sales and earnings growth at its health-care division in the next three years, pegging the yearly sales potential of its top drugs at EUR7.5 billion . The Leverkusen-based company, which is preparing to spin off its high-tech plastics business, said on Wednesday that combined sales of its top drugs--the anticoagulant Xarelto, the eye medicine Eylea, the cancer drugs Stivarga and Xofigo, and the pulmonary hypertension drug Adempas--should rise toward EUR4 billion in this year Bayer said it aims to increase health-care revenue by an average of about 6% a year through 2017 to more than EUR25 billion.
Tags: plans
chemicals
ipo
bayer
Category:Chemicals